Inicio › Cáncer (todos los tipos) › Nueva York › Buffalo
Ensayos clínicos de Cáncer (todos los tipos) en Buffalo, NY
19 estudios para Cáncer (todos los tipos) buscan participantes en centros de Buffalo y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of ASP3082 in Adults With Advanced Solid Tumors
ReclutandoFase 1
- Roswell Park Cancer Institute, Buffalo
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
ReclutandoFase 3
- Quetzal Site 4, Buffalo
Intratumoral N17350 in Advanced Solid Tumors
ReclutandoFase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
ReclutandoEstudio observacional
- Roswell Park Comprehensive Cancer Center, Buffalo
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
ReclutandoFase 2/3
- Roswell Park Cancer Institute, Buffalo
Collection of Tissue Samples for Cancer Research
ReclutandoEstudio observacional
- Roswell Park Cancer Institute, Buffalo
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
ReclutandoFase 2
- Roswell Park Center Institute, Buffalo
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Roswell Park Cancer Institute, Buffalo
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
ReclutandoFase 1
- Roswell Park Cancer Institute, Buffalo
Childhood Cancer Survivor Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Roswell Park Cancer Institute, Buffalo
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
ReclutandoFase 1
- Roswell Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ReclutandoFase 2
- Roswell Park Cancer Institute, Buffalo
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
ReclutandoFase 1
- Roswell Park, Buffalo
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
Reclutando
- University at Buffalo / Great Lakes Cancer Care, Buffalo
Cannabis Use and Outcomes in Black and White Patients With Cancer
ReclutandoEstudio observacional
- University at Buffalo, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Buffalo
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutando
- Roswell Park Cancer Institute, Buffalo
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
ReclutandoFase 1/2
- Roswell Park Cancer Institute, Buffalo
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX121 estudios
- New York City, NY109 estudios
- Boston, MA85 estudios
- Los Angeles, CA74 estudios
- Nashville, TN65 estudios
- Philadelphia, PA59 estudios
- Washington, DC58 estudios
- Durham, NC58 estudios
- Chicago, IL51 estudios
- Atlanta, GA49 estudios
- Seattle, WA49 estudios
- Arlington, VA48 estudios
Otros estudios en Buffalo
- Cáncer de pulmón de células no pequeñas19 estudios
- Leucemia mielógena aguda19 estudios
- Cáncer de pulmón16 estudios
- Cáncer de seno16 estudios
- Cáncer de ovario13 estudios
- Cáncer metastásico11 estudios
- Cáncer de próstata11 estudios
- Melanoma10 estudios
- Mieloma múltiple10 estudios
- Obesidad9 estudios
- Linfoma de Burkitt8 estudios
- Síndromes mielodisplásicos8 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.